Peggy Harbison, V.M.D.
Peggy Harbison, V.M.D., Senior Vice President Preclinical and Program Management
has had 20 years experience in drug and companion diagnostics development at Roche
with particular expertise in project leadership, clinical and regulatory strategies, and preclinical drug development.
Most recently, she was Vice President at Roche Molecular Diagnostics where she was responsible for a development portfolio of molecular biomarker and companion diagnostics in the Genomics and Oncology business area.
Prior to that, Dr. Harbison held global project leadership positions in the Pharma division; she led cross-functional lifecycle teams for drugs in development, both small molecules and biologics, in a variety of therapeutic areas.
tenure included a 4-year ex-pat assignment in the Basel, Switzerland headquarters and the position of Global Head of Project Management.
Dr. Harbison spent her initial years at Roche in preclinical drug development in the Department of Toxicology and Pathology.
She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania.
pathology training was carried out at Harvard Medical School
under an National Institutes of Health post-doctoral fellowship.